We aim to foster a culture of entrepreneurship, innovation and success among engineers in the UK, creating economic growth and societal impact. At the heart of how we do this are the Hub Members, the promising entrepreneurs who we support through our programmes, and our Hub Mentors, the business leaders who volunteer their expertise and time to help the Hub Members succeed.
From manufacturing to medtech, our Hub Membership is made up of some of the UK’s most innovative entrepreneurs. But don’t just take our word for it: read more about our Hub Members to see how they are, without exaggeration, changing the world.
Dr Kai Yang has developed an everyday fabric-based electrode for wearable medical devices so that stroke sufferers and people in need of pain relief can get electrical stimulation treatment in a far more practical way than ever before.
Traditional electrodes (made from hydrogel) are not ideal for wearable applications as they are sticky, have a limited lifetime, need to be kept in a sealed bag to stop moisture evaporation, and are incompatible with clothing.
Dr Kai Yang's fabric electrode can be applied on the skin directly without using any gel. Everyday fabrics and clothing items such as an arm band or sleeve can have the electrodes added to suit various needs. The fabric-based electrode is comfortable to wear, easy to use, washable and unobtrusive.
The fabric electrode can be used to deliver Functional Electrical Stimulation (FES) for stroke rehabilitation; TENS for pain relief (e.g. arthritis, back pain, neck pain) and health monitoring (e.g. ECG, EEG, EMG).
As a Principal Investigator, Kai has secured £1.1M research funding from the Medical Research Council for a multi-disciplinary team to develop a wearable FES training system for home based stroke rehabilitation using the fabric electrode together with advanced control and sensor technologies. The FES training system will enable stroke survivors to conduct rehabilitation activities without the need of a carer or therapist.
Flexible, touch-sensitive materials could enhance usability in a range of electronics. TG0 has developed a new technology for interactive 3D controls that are ergonomic, intuitive and engaging.
TG0’s technology is driven by artificial intelligence algorithms and advanced signal processing to accurately detect variations in touch across a single flexible surface. The material can easily sense pressure, location, speed, direction and movement.
TG0’s seamless, interactive surfaces replace complicated networks of electronic sensors with one material. It can be used in many applications including tactile gaming controls, car dashboard controls and ergonomic computer accessories such as keyboards. It could also be used for accessible interactive products for visually impaired people.
Dr Liucheng Guo, Chief Technical Officer, co-founded the company and leads innovation in TG0’s software and hardware co-design. Supported by the SME Leaders Programme, Liucheng wants to increase the company’s customer base and expand its product portfolio. Liucheng will use training and development through the programme to guide him in leading a rapidly growing software and hardware team, as TG0 extends into a range of industries including sensor-embedded industrial robots, wearables, gadgets and underwater electronics.
Daniel is the inventor of RHEON™ and CTO of RHEON LABS.
RHEON is a revolutionary mouldable material that is capable of absorbing high levels of energy in impact, tension and vibration. It uses a property known as strain-rate dependency to allow this material to be flexible in normal wearing, but to stiffen instantaneously and temporarily when subject to an acute energy input. It can be moulded directly onto clothing, incorporated into the fabric as a thread or coating, or laminated onto a material and is both breathable and washable.
Daniel has worked in the field of energy absorbing systems and their applications for over 15 years, including specialisation work in smart textiles for NASA and sitting on the London 2012 Olympic committee. During his PhD, the fellowship and throughout his work since has built up a significant portfolio of patents which are now being exploited for the sports sector through RHEON LABS Ltd.
The scientists, engineers and designers at RHEON LABS are already engaged with best-in-class brands across a wide spectrum of sports apparel, collaborating with some of the biggest names to integrate RHEON™ into their products to enhance the performance, comfort and protection.
Poised now for rapid growth, Daniel and RHEON LABS are building a team to widen the commercialisation of this exciting technology. Whilst the initial focus is on the sports-apparel sector, there are significant opportunities for applying this potentially life-saving technology in several other sectors such as electronics, healthcare and defence.
“For me, the opportunity to work for an extended period with one product and a single focus is very welcome. The highly relevant and focused mentorship, and the prestige of growing my business under the Academy scheme, is too good an opportunity to ignore.”
Jon has developed software to help drug developers predict the effects of new drugs on auto-immune diseases, such as rheumatoid arthritis and multiple sclerosis.
His software is capable of integrating far more data and concepts than the systems currently used by drug developers creating clinical trials of new products. The increased data input through Jon's system results in improved confidence in computer simulations, cost savings and quicker speed to market for new drug releases.
Jon is Professor of Intelligent and Adaptive Systems at the University of York, where his research focuses on building computer models of immune function in the human body. He is the founder of SimOmics, a spin out of the University of York, which is expanding on these developments.
Philip is the founder of Synaptec Ltd and is pioneering new photonic sensor and interrogator designs for complex modern energy systems like smart grids.
His technology eliminates the need to duplicate expensive measurement hardware. This is achieved by getting simultaneous measurements of electrical parameters from across the power grid, without bandwidth limitations and with minimal infrastructure.
Synaptec reduces electrical power transmission costs through reducing outages, preventing circuit damage, and minimising civil works. These low-carbon technologies are what will underpin electric power generation and distribution in the future.
He is also working with the industry to improve power system protection capabilities by removing the bottlenecks that often take place with present methods.
“It’s the combination of marketing, networking and training opportunities that makes the Enterprise Hub such a unique opportunity, and it would simply be impossible for me to focus on beginning to commercialise this technology without its support. The opportunities to access potential investors, mentors, and a community of academic entrepreneurial peers will be invaluable.”
Working in tandem with PhD student Robert Rudolf, Reuben developed the first instance of technology that will allow energy consumed by mains connected equipment to be measured without the need for a monitor between the equipment and the wall socket.
The technology uses state of the art sensors with elegant calibration and measurement algorithms.
This resulted in an innovative new device that is a non-invasive multi-core current clamp which can be fitted around a cable and removed with ease. This approach removes the need to access sockets and to power down equipment for the fitting process.
Reuben's spinout company, Joulo, was acquired in 2015 Quby, Europe’s leading develop of smart thermostats and energy displays.
Following the sale of Joulo, Reuben co-founded Future Worlds, an on-campus startup incubator helping aspiring entrepreneurs to change the world with their ideas at the University of Southampton.
“Being involved with the Hub has been extremely useful with its opportunities to network with experienced business owners and entrepreneurs, many of whom have experienced the difficult decisions we are facing numerous times before. There is no question that these opportunities are vital to developing business ideas and raising the profile of our technology.”
Major advances in fabrication techniques now allows the building of new materials and devices on an atomic or molecular scale. These engineered materials can offer great advantages such as increased energy efficiency, strength, antibacterial properties and more. Their potential is vast, and very exciting to a range of industry sectors from medicine to aircraft manufacture.
To use - and continue to advance - the possibilities of these nano-engineered materials requires tools that can efficiently measure and characterise their properties.
Oliver is working to transform high-speed atomic force microscopy (HSAFM) into a diagnostic and fabrication tool to do precisely this.
His work is up to the challenge posed by imaging nano scale structures over sample areas which are industrially relevant. HSAFM is capable of imaging areas several thousand times faster than conventional atomic force microscopy (AFM).
Oliver's research at the University of Bristol will provide a tool to produce terra-pixel sized 3D images of surfaces. It will also be capable of rapidly prototyping nano structures over centimetre-sized areas in a matter of hours.
Mapping, measuring and manufacturing nanostructures via high-speed atomic force microscopy is now a possibility!
Ian is the Managing Director of TribeHive, a University of Sussex spin-out focussing on software to overcome the problem of poor smartphone data connectivity in crowded places.
His innovation lets individual smartphone apps crowd-share data bandwidth by building a network directly between the mobile devices. This network is then used as the basis for distributing information.
Using this technology, mobile apps can reliably deliver match-related content and social media feeds to football fans in stadiums.
The system is now in place in a large number of professional football clubs, and the commercial rights in the sports market have now passed on to the company InCrowd Sports. Working with TribeHive, Ian continues to develop other opportunities for the technology.
“The Enterprise Hub has provided me access to very high calibre mentors, who have considerable experience in the field. It is immensely useful to be able to bounce ideas off them, sanity check our plans, and discuss freely with an independent and smart mind how best to move the business forward.”
Julien has developed a 30-minute test for infections that could revolutionise the detection and treatment of significant diseases.
He is a co-founder of SAW Dx, which has designed a testing procedure that is completely automated and carried out on a low-cost handheld system. Significantly, it can be used to test and identify major diseases (including chlamydia, gonorrhoea and malaria) that require costly lab work and a stressful wait for the patient.
new test system allows the manipulation of microvolumes of
fluids, such as a finger-prick sample of blood.
Designed to be a completely integrated sample-to-answer diagnostic test for patients at the point of care, the technology overcomes the limitations that current solutions have handling complex samples such as blood or saliva.
“The Hub has been very beneficial for my work all round, and I expect to deepen the interactions with my fellow members and continue participating with the targeted workshops and seminars. The original interview process for the ERA award was also valuable, with a significant part of the process devoted not to simply grilling me on my project, but offering very useful advice on the best way forward.”
What makes us different is the Academy’s Fellows and our wider Mentor network – an unrivalled community of the UK’s most successful industry leaders, technology experts and entrepreneurs. Find out more about our Mentors and their areas of expertise.
Dr Supti Sarkar leads the Technology and Investments Group at PwC. She is responsible for the commercialisation of new tech ventures across the firm, and works with in-house entrepreneurs to get their products market ready.
Supti was formally a management consultant at PA Consulting, where she worked with international and regional governments to support their trade and investment strategies. She was also part of Mayor Sadiq Khan's 2016 delegation to Chicago and New York as part of her role in supporting high growth companies entering the US market for the first time. Supti holds a first class degree and PhD in engineering from University College London and is mum to an eight-year-old daughter.
Dr Douglas C Anderson OBE FREng FRSE has a 40-year business career covering almost every aspect, at every level, of healthcare technology product design and product commercialisation processes.
Having trained in industrial design engineering (Edinburgh Napier University 1974), Douglas progressed from hands on designer to the management of design in the high-tech arena.
Using his consulting company Crombie Anderson as a base for innovation and incubation, he subsequently spun out three other high-tech startup companies, two of which became publicly traded business operating in medical fields.
Douglas was the prime mover in these businesses by leading both the innovation and commercialisation processes, including raising over £40 million in private and institutional funding prior to floatation. Today he is internationally recognised for his innovation and entrepreneurial experience and is a regular keynote speaker at healthcare and business congresses around the world.
In 1990, his five-year-old son Leif suffered a spontaneous retinal detachment that went undetected until it was too late to treat. Douglas was struck by the limited capability of diagnostic tools available to practitioners to examine the retina and decided to address this issue. He built a dedicated research team, which led to the formation of Optos plc, a business funded by Archangel from the outset.
Optos succeeded in designing and patenting a scanning laser ophthalmoscope: the world's first ophthalmic device that enabled eye care professionals to capture a digital ultra wide-field image of the almost the entire retina in a single scan. The new method of examining the retina, marketed as the optomap® Retinal Exam, is now offered as the preferred standard of care by tens of thousands of eye-care specialists globally. Over 200 million optomap® retinal exams have been conducted worldwide and a number of novel diagnostic techniques added to improve the understanding and treatment of a wider range of conditions that have been historically difficult to manage.
In 2006 Douglas was awarded an OBE for services to healthcare. Douglas was elected a Fellow of the Royal Academy of Engineering in 2013.
David is an investor and CEO with companies based on technology and innovation.
After a degree in electrical engineering at the Technion and an MBA from INSEAD, David worked his way to senior management and board level in a wide range of sectors including sustainability, construction, life sciences, manufacturing, mobile telephony, cyber security and software. His broad experience ranges from startups to public companies, from turnaround missions and crisis management to business development and growth.
David is deeply involved in the UK startup space, as a member of UKBAA, VCs, EIS funds and university angel groups, and is an active mentor with the Royal Academy of Engineering and Imperial College London’s IVMS programme. He also serves as a non-executive on the board of directors of Kerur Holdings (a public company), the board of governors of the Technion, as an advisor with the US accelerator Silicon Catalyst and the board of trustees of Hadassah UK.
He believes that success comes from a culture of excellence, a multidisciplinary approach, and that the boundaries between B2B/B2C and startups/LargeCo are increasingly blurred.
"Startups challenge and can defeat established companies. An explosion of new technologies will accelerate this trend. Large companies cannot afford to be on the defensive, they must proactively adopt a startup culture. But startups must also learn to be humble and pragmatic, build structures, communicate at a senior level, and strive to serve all their stakeholders, clients, staff, investors, and society as a whole. A fusion of cultures is now pivotal to success."
Richard joined sustainability investment focused Earth Capital Group in 2009 and has worked both on the group’s investment in investment managers and direct growth company investments, including most recently the fund’s investments in SoftIron and Propelair. He takes a leading role in promoting technology transfer opportunities across the group’s international offices.
Prior to joining Earth Capital, Richard was an Investment Director with IBIS Asset Management Ltd, a London-based captive advisor to a large Caribbean conglomerate. Richard was earlier a senior manager in the London office of L.E.K. Consulting, a global strategy consultancy. During his five years with LEK he provided due diligence advice, in numerous large cap and mid-market private equity deals, and advised corporate clients on corporate strategy, business unit growth strategy, process redesign and cost reduction programmes.
A chartered engineer, his early career included successful engineering, operations and customer support management roles with Ford Motor Company and Visteon Corporation. Richard holds an MBA with Distinction from INSEAD and MEng and MA (First Class) degrees in engineering from the University of Cambridge. He is a chartered member of the Chartered Institute of Securities and Investment, and a Chartered Member of the Institute of Engineering and Technology and a Sainsbury Management Fellow.
Dr Andrew Hosty FREng is an international leader with over 15 years of non-executive board experience and 30 years of executive and management experience, spanning private equity, UK Plc and global blue-chip corporates. He is non-executive director of a companies including: RHI-Magnesita, the global leader in the manufacture and supply of refractories; James Cropper Plc, who create some of the world’s most distinctive and technically advanced paper products; and Rights and Issues Investment Trust Plc, a fund that focuses on small cap UK industrials.
Andrew is Non-Executive Chairman of mOm Incubators ltd, a pre-revenue startup developing low-cost baby incubators for crisis zones. He is also Non-Executive Chairman of Nexeon ltd, a company developing next-generation cathode materials for lithium-ion batteries. From 2016 to 2018 Andrew was the CEO of the Sir Henry Royce Institute, the UK's home of advanced materials research and innovation. He was Chief Operating Officer of Morgan Advanced Materials, and served on the Plc Board as an Executive Director from 2010 to 2016.
From 2013 to 2016 he served on the board
of Consort Medical Plc, a healthcare company focused on developing advanced
delivery technologies, formulation and manufacturing solutions for drugs. He is
a Fellow of the Institute of Materials, holds a PhD from the Faculty of
Engineering at the University of Sheffield and is a Fellow of the Royal Academy
of Engineering (2011).
Chris McIntosh joined Methera Global as CEO in 2017. The company’s vision is to enable the delivery of digital applications to rural and underserved communities worldwide via a resilient constellation of Ka band MEO satellites. He previously spent seven years as CEO of ViaSat UK where he was responsible for the inception and growth of ViaSat’s UK satellite capabilities. Headquartered in the US, ViaSat are renowned as being one of the most disruptive players in the satellite communications and security domain.
Before joining ViaSat Chris was CEO of Stonewood Group, developers of state-of-the-art cyber products and services. He is a retired Lieutenant Colonel from the British Army and has worked within the challenging, high threat cyber and communications environment for over 30 years. He holds a BSc in computer science, MSc in design of computer systems and an MBA. He is a member of the UKspace trade association and the National Security and Resilience Consortium, and is a chartered engineer.
Roy Williamson has been helping companies see how their new innovations can disrupt markets for over 20 years.
For the past six years has been successfully helping early stage companies identify and define their strengths, enhance their uniqueness and develop their storylines to engage investors. Roy’s background is in engineering and cleantech and since 2013, he’s been supporting SMEs and entrepreneurs across a broad area of technologies and innovative business models.
Roy is an aeronautical engineer and started his career at Alstom, developing algorithms and models to estimate hardware costs of power generation gas turbines based purely on, often novel, thermodynamic cycles. He has assessed innovation ecosystems of the UK, published by the Organisation for Economic Co-operation and Development. He has also co-authored guides to support technology developers in the UK automotive sector assess technology readiness levels and help those in the biofuels sector to review pathways for second generation biofuels. He’s appraised novel technology solutions for blue-chip clients, developed proof of concepts and carried out due diligence activities to support investor decision making. He is passionate about the UK and knowledge-intensive companies, from software to deeptech.
Roy is Head of Origination at the Department for International Trade with relationships across the department’s teams, government and the UK’s innovation and investment ecosystem.
Professor Mark Arthur Tooley FREng is the immediate Past President of the Institute of Physics and Engineering in Medicine. He was the Head of the Department of Medical Physics and Bioengineering and Director of Research and Development at the Royal United Hospitals, Bath until 2017 when he retired from full-time NHS work. Since then, he has held several part-time roles. He is a specialist scientific advisor for NHS England, a digital clinical advisor for the West of England Academic Health Science network, and a healthcare technology consultant. He is a registered Consultant Clinical Scientist, an honorary professor at the University of Bath, and a visiting professor at the University of the West of England.
Mark completed his BSc in Electrical and Electronic Engineering at the University of Bath in 1979. He was sponsored by Westinghouse Brake and Signal company for the four years of the course. He then did an MSc and PhD in Medical Physics at the University of London. His MSc thesis was developing a EEG frequency analyser for anaesthesia. For his PhD research, Mark invented (with a cardiologist) an original method for rate-independent diagnosis of cardiac rhythm for implantable devices, which was patented. He spent the rest of his career in Medical Physics and Bioengineering departments, both in hospitals and academia, working along medical colleagues. He has worked at St Bartholomew’s hospital in London, Bristol University, United Bristol healthcare NHS Trust, and the Royal United Hospital, Bath. He is a Fellow of the Royal Academy of Engineering, the Royal College of Physicians, the Institute of Engineering and Technology, the Institute of Physics and Engineering in Medicine, and the Institute of Physics. He is a chartered engineer and chartered scientist. Mark is on the peer-review college of EPSRC, has recently been a member of the Engineering and Physical Sciences Research Council Healthcare Technologies Strategic Advisory Team and the Royal Society Fellowship panel.
Mark has been a long-standing member of the Panel for Biomedical Engineering at the Royal Academy of Engineering (now called the healthcare policy topic group). He was recently a member of the biomedical engineering membership panel, the Policy Committee, and the working group for Systems thinking in healthcare. He has mentored on the enterprise scheme.
Mark’s research interests include innovations in medicine, physics applications in anaesthesia, simulation in medicine, physiological measurement, biological signal processing, measuring the depth of anaesthesia, blood pressure measurement and novel patient monitoring solutions.
Dr Liane Smith FREng founded Intetech Ltd in 1991, winning the Queen’s Award for Innovation in 2012 for its software. She sold the business to Wood Group in 2013 and in 2018 she left to form a new consulting engineering business, Larkton Ltd.
Liane is enthusiastic about the capability of digital technologies to transform businesses, bringing efficiencies, cost reduction, production control and increasing safety. In her last role as Senior Vice President Digital Solutions for Wood, she built the new global service line and defined its strategy roadmap and development plan. Her expertise is in various specialist branches of engineering in the industrial and energy sectors and in software product design and commercialisation, data management, data analysis, and analytics.
“I try to fill in gaps in mentees experience and give them confidence in their decisions. Typically we touch on building strong teams, role and task delegation, agile development, growing sales, exporting and strategy."